Research Reports

Key takeaways

Policy covers Vice Presidents and above, excluding CEO, who must sign participation agreement and execute release.

Standard termination benefits: 9-15 months base salary and COBRA premiums based on title (VP:9, SVP:12, EVP:15 months).

Change in Control period (3 months prior to 12 months post): adds 9-15 months target bonus, prorated bonus, full equity vesting acceleration.

Policy effective until April 23, 2033, unless terminated earlier; administered by Human Capital Management & Compensation Committee.

No duplication of benefits if individual agreements provide lesser severance; supersedes if policy benefits greater.

Full analysis

The adoption of the Executive Severance Policy standardizes and enhances severance protections for Xencor's senior leadership team excluding the CEO, potentially increasing retention amid talent competition in biotech. Tiered benefits align with seniority, with enhanced 'double-trigger' protections during Change in Control periods to safeguard executives from deal-related disruptions, including full acceleration of equity awards. This could signal board preparedness for strategic transactions or leadership stability measures, administered by the compensation committee with Section 409A compliance to avoid tax penalties. Investors should note the policy's 7-year term and override of lesser individual agreements, standardizing costs in termination scenarios.

XNCR · Xencor, Inc.

Summary

Key takeaways

Full analysis